10: How the MDR has changed the roles and responsibilities of “economic operators”
PharmaLex Talks8 Elo 2022

10: How the MDR has changed the roles and responsibilities of “economic operators”

Under the Medical Devices Regulation economic operators – that is manufacturers, the authorised representative, importers and distributors – all face new roles and obligations. While some of these responsibilities existed under the Medical Devices Directive, workload will be impacted. From requirements around Eudamed, to having a person responsible for regulatory compliance, to ensuring certain obligations are properly followed through to complaint management, the roles of all economic operators are affected and require careful consideration by companies with devices in the European market.

Clare Huntington is Director and Head of Medical Devices / IVD UK at PharmaLex

Clare leads the UK and EU teams and consults on industry-wide issues including drug/device combination products, clinical trials, device classification and regulatory submissions, and post-market requirements. Clare has worked in a variety of roles in the medical device space during her career, including the MHRA, a Clinical Research Organisation, as an EU Authorised Representative, as well as industry, leading the regulatory affairs activities. This has given her a broad understanding of the EU regulatory landscape which enables her to provide comprehensive advice to clients that covers the full product life-cycle.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

21: Navigating a complex global regulatory environment to bring medicinal products to market

21: Navigating a complex global regulatory environment to bring medicinal products to market

The pharmaceutical industry has been globalizing for many years as demand for medicinal products grows and as companies look to expand into the large and increasingly prosperous emerging markets. The ...

18 Heinä 202313min

20: Safety Reporting Requirements for Marketing in the EU

20: Safety Reporting Requirements for Marketing in the EU

For US-based companies seeking to market their product in the EU, it can be a struggle to navigate a different market, and, in particular, to manage requirements from a safety reporting perspective. T...

6 Heinä 202320min

19: The important role of AI in TMF oversight

19: The important role of AI in TMF oversight

Artificial intelligence is playing an increasingly important role in document management in the life sciences industry and in particular in improving management and oversight of the Trial Master File ...

24 Touko 202312min

18: Tackling performance requirements in the more prescriptive world of IVDR

18: Tackling performance requirements in the more prescriptive world of IVDR

Summary: IVD manufacturers must perform two types of performance studies, clinical performance and analytical performance, in order to provide evidence that the device is safe and performs as intended...

5 Huhti 202313min

17: Gaining efficiencies with custom statistical solutions in a GxP setting

17: Gaining efficiencies with custom statistical solutions in a GxP setting

Summary: A lot of statistical work within pharmaceutical companies is repetitive and this costs money and resources, especially if it’s done within GxP environments where there is often a need for dou...

15 Maalis 202313min

16: How the quality culture impacts GMP activity

16: How the quality culture impacts GMP activity

A strong quality culture in the biopharmaceutical industry is one in which all participants in the organization understand patient safety and how their roles impact patient safety risks. It is one whe...

22 Helmi 202321min

15: Managing the medical device pre-submission process with the FDA

15: Managing the medical device pre-submission process with the FDA

There are unique considerations and nuances to the US Food and Drug Administration’s (FDA) pre-submission process for medical devices that companies need to consider. Known as the Q-submission (Q-sub)...

17 Tammi 202314min

14: Digitalization as a tool in the outsourcing journey

14: Digitalization as a tool in the outsourcing journey

With pharmaceutical companies increasingly turning to outsourcing partners to support maintenance of marketed products, efficiency and reliability are imperative. Digitalization, in particular automat...

9 Tammi 202312min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
politiikan-puskaradio
rss-ootsa-kuullut-tasta
ootsa-kuullut-tasta-2
rss-vaalirankkurit-podcast
tervo-halme
otetaan-yhdet
rss-podme-livebox
viisupodi
et-sa-noin-voi-sanoo-esittaa
rss-pinnalla
rss-asiastudio
rss-girls-finish-f1rst
linda-maria
rss-raha-talous-ja-politiikka
rss-ulkopoditiikkaa
rikosmyytit
the-ulkopolitist
rss-polikulaari-pitka-kiekko-ja-muut-ts-podcastit